Inconsistent guidelines for screening transplant recipients at higher cancer risk

August 30, 2016
Dr. Nancy Baxter, senior author of the review and chief of the General Surgery Department at St. Michael's, said the review found that most of the guidelines were written only by transplant specialists and did not involve oncologists, primary care physicians, public health officials or patients. Credit: St. Michael's Hospital

People who have received organ transplants are at higher risk of developing and dying of cancer than the general population. Yet a new study has found cancer screening guidelines for this group are inconsistent as is the use of these guidelines.

Researchers at St. Michael's Hospital did an international systematic review and found only 13 sets of - recommendations for optimizing patient care generally based on evidence - for cancer screening of . Most were for as kidneys are the most commonly transplanted organ.

Their findings were published online today in the American Journal of Transplantation.

Dr. Nancy Baxter, senior author of the review and chief of the General Surgery Department at St. Michael's, said the review found that most of the guidelines were written only by transplant specialists and did not involve oncologists, primary care physicians, public health officials or patients.

She said none of the guidelines were based on evidence collected during clinical trials - a situation unlikely to change given that clinical trials require large numbers of people to provide accurate data and the transplant population is relatively small.

Dr. Sergio Acuna, the study's lead author and a physician and PhD student in clinical epidemiology at St. Michael's, said the existing guidelines generally recommend that transplant recipients should receive the same level of cancer screening as the .

Most of the guidelines recommended transplant patients be screened for skin cancer, but varied considerably on recommendations for other types of cancer, such as breast, cervical or colorectal cancer.

Previous work by Drs. Baxter and Acuna found that people who had were three times more likely to die from cancer than the general population and that cancer was the leading cause of death among these patients. The risk of developing and dying from cancer was highest among children.

"Transplant recipients should be aware they have a heightened risk of developing and dying from cancer and should advocate with their health-care providers to be screened for cancer," said Dr. Baxter. "Even though transplant recipients often have other serious medical conditions that could shorten their life expectancy, they also need to be screened for cancer to ensure early detection."

The authors said more studies were needed to inform screening guidelines for transplant recipients and guideline development should involve , oncologists and specialists.

Their work relates to solid organs such as the heart, lung, liver and kidneys, but not hollow organs such as intestines or non-solid tissues such as bone marrow or blood.

Explore further: Organ recipients with previous cancers linked to higher death rates, new cancers

Related Stories

Organ recipients with previous cancers linked to higher death rates, new cancers

April 22, 2016
People who had cancer before receiving an organ transplant were more likely to die of any cause, die of cancer or develop a new cancer than organ recipients who did not previously have cancer, a new paper has found. However, ...

Higher cancer death rate associated with solid-organ transplant recipients

January 7, 2016
In solid-organ transplant recipients, the cancer death rate was higher than in the general population in a new study from Ontario, Canada, published online by JAMA Oncology.

Patients with a certain form of kidney disease may have a reduced risk of cancer

May 22, 2014
Patients with a certain form of kidney disease may have a reduced risk of cancer compared with patients with other kidney diseases, according to a study appearing in an upcoming issue of the Journal of the American Society ...

Screening male kidney transplant candidates for prostate cancer may do more harm than good

December 22, 2015
Screening male kidney transplant candidates for prostate cancer may be more harmful than protective because it does not appear to prolong their survival but may interfere with the transplant process. The findings come from ...

Lip cancer risk up for some solid organ transplant recipients

May 24, 2016
(HealthDay)—For solid organ transplant recipients, azathioprine dose and duration of immunosuppression are associated with increased risk of lip cancer, according to a study published in the June issue of the Journal of ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.